Metformin use did not appear to reduce the risk of bladder cancer in patients with type 2 diabetes, a study in Diabetes Care indicated. Researchers examined 87,600 patients and found no reduction in bladder cancer risk with increased duration of metformin use compared with the use of sulfonylureas.

Related Summaries